NDC 72786-101

OXBRYTA

Voxelotor

OXBRYTA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Global Blood Therapeutics Inc.. The primary component is Voxelotor.

• Product ID: 72786-101_0f829f12-5b00-4e7f-9261-377702f5a2a3
• NDC: 72786-101
• Product Type: Human Prescription Drug
• Proprietary Name: OXBRYTA
• Generic Name: Voxelotor
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2019-11-25
• Marketing Category: NDA / NDA
• Application Number: NDA213137
• Labeler Name: Global Blood Therapeutics Inc.
• Substance Name: VOXELOTOR
• Active Ingredient Strength: 500 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72786-101-01

90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-101-01)

• Marketing Start Date: 2019-11-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72786-101-01 [72786010101]

OXBRYTA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA213137
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-11-25

Drug Details

Active Ingredients

Ingredient	Strength
VOXELOTOR	500 mg/1

NDC Crossover Matching brand name "OXBRYTA" or generic name "Voxelotor"

NDC	Brand Name	Generic Name
72786-101	OXBRYTA	Voxelotor
72786-102	OXBRYTA	Voxelotor
72786-111	OXBRYTA	Voxelotor